BioVisible (founded 2006) is specialised in fast detection and identification of micro-organisms using molecular biological techniques.
Scope; “Research, development, analysis services, production and commercialisation of Molecular Microbial Diagnostics for detection and identification of microorganisms”.
The following activities belong to the core business activities of BioVisible:
(1) Client specific research activities on contract basis
(2) Development and sales of molecular, biological testkits, -systems and products for the detection and identification of micro-organisms.
(3) Routine analysis for third parties.
(4) Client specific implementation of developed tests & training.
BioVisible sells molecular, biological testkits under the name RiboTechnologies with world-wide sales. Focus areas are intestinal micro-flora diagnosis, sepsis and environmental diagnosis. New products are developed in-house and in close cooperation with international universities and innovative companies in order to rapidly expand our business. RiboTechnologies has direct sales and a worldwide network of distributors.
Focus is on biodefense and intestinal micro-flora applications.
BioVisible develops, ‘tailor-made’, advanced diagnostic tests based on DNA technology in the R&D unit. Based on the R&D developments BioVisible offers Molecular Diagnostic analysis services, mostly for the analysis of intestinal microflora and BioVisible manufactures and sells Molecular Diagnostic assays. Products are sold under the trade name RiboTechnologies®. The business model is based on a cycle where developments and questions from the market induce new developments in the R&D unit.
If you have any questions or you wish to receive more information please do not hesitate to contact us. For discussion of your specific requests please contact Dr. M.E. van der Rest: email@example.com
BioVisible starts a new analysis service using the Mitox™ DNA - Mitochondrial toxicity assay to measure simultaneously the nuclear DNA and mitochondrial RNA content of the cell. This assay can be used as a biomarker for toxicity and/or efficacy of antiviral treatment.
This analysis service is offered in collaboration with Primagen. Click Logo for preliminary website.
Did you know; Jean Genevieve Garnerin was the first female parachutists, jumping from a hot air balloon in 1799.